MENLO PARK, Calif. - June 22, 2023 - PRLog -- LamdaGen Corporation, an emerging technology company with a powerful, plasmonic platform for rapid diagnostic/detection testing, is pleased to announce the members of its newly-formed Strategic Advisory Board (SAB).

The inaugural SAB members represent a distinguished set of experts who bring a depth of leadership, innovation and product commercialization experience in the life science, diagnostic, pharmaceutical and food safety industries.

"We are honored to be working with a team of respected individuals whose scientific and industry expertise directly relate to the work we have underway," commented Randolph Storer, CEO and co-founder of LamdaGen. "Their insights will significantly help us leverage the progress we've made, and guide us towards bringing innovative testing solutions to market."

LamdaGen welcomes Dr. Richard Eglen as Chairman, and John Verrant and Dr. Martin Easter who join Mr. Storer on the SAB.

Dr. Richard Eglen is a distinguished veteran of the pharmaceutical, diagnostic, and biotech industries and has held numerous executive positions over the past 40 years. His past roles include Vice President and General Manager of Corning Life Sciences, President of Bio-discovery at PerkinElmer, Executive Vice President for research and development at DiscoveRx Corp, and Vice President of the Center for Biological Research at Roche Pharmaceuticals. He has authored over 320 publications, book chapters, and patents, and serves on several industry, academic, and editorial boards.

John Verrant is a leader in medical device development, with hands-on experience taking new technologies from platform development to product launch. Mr. Verrant recently retired as Senior Principal Scientist, Medical Digital & Technical Solutions Infectious Diseases at Janssen/Johnson & Johnson, where he led efforts implementing diagnostic solutions into clinical trials, and mentored early stage companies towards commercialization. Mr. Verrant has held product development leadership roles with Abbott Diagnostics, Abbott Point of Care and others, bringing forward innovative optical detection systems.

Dr. Martin Easter is the Co-Founder and recently retired Chief Scientific Officer of Hygiena, a global developer, producer and provider of best-in-class food safety diagnostic solutions throughout the farm-to-fork value chain. Dr. Easter pioneered the development of rapid test methods based on ATP bioluminescence for the Food Safety industry, which was integral to revolutionizing ATP hygiene testing with improved performance, reliability and affordability. He and has over 35 years of experience as a business leader and industrial microbiologist innovator.

About LamdaGen Corporation

LamdaGen is an innovative technology holding company at the forefront of developing and integrating powerful plasmonic biosensors for rapid point-of-use testing systems in the Human Health, Animal Health and Food Safety sectors.

Our vision is to advance biosensing by consistently pushing the boundaries of sensitivity, speed, and precision. We are committed to delivering cutting-edge detection solutions to improve the quality of human, animal and environmental health.